- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Anti-Aging
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
New developments in skin cancer surveyed
After surveying research done in the United States and in other countries, Clark C. Otley, M.D., of the Mayo Clinic, examined the latest developments in the diagnosis and treatment of cutaneous oncology.
After surveying research done in the United States and in other countries, Clark C. Otley, M.D., of the Mayo Clinic, examined the latest developments in the diagnosis and treatment of cutaneous oncology.
Dr. Otley also reviewed studies of prognostic data for Merkel cell carcinoma.
"We have also found in another study from the Mayo Clinic published in 2002 that the results from a sentinel lymph node biopsy predict a person's outcome from Merkel cell carcinoma," says Dr. Otley.
Dr. Otley also discussed developments in transplant oncology.
"Skin cancer in solid organ transplant patients represents a substantial problem," he adds.
